Lv11
30 积分 2025-08-18 加入
Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
5小时前
待确认
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
6小时前
已完结
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
2天前
已关闭
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial
5天前
已完结
Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer
6天前
已完结
Updated results from a dose and schedule study of Panitumumab (ABX-EGF) monotherapy, in patients with advanced solid malignancies
6天前
已关闭
Panitumumab the first fully human monoclonal antibody: from the bench to the clinic
6天前
已完结
Phase I study of the second-generation, recombinant, human EGFR antibody necitumumab in Japanese patients with advanced solid tumors
9天前
已完结
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies
10天前
已完结
Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study
10天前
已完结
皖公网安备34019202002308
